Low-Dose-Rate Brachytherapy
Cross-source consensus on Low-Dose-Rate Brachytherapy from 1 sources and 6 claims.
1 sources · 6 claims
Uses
How it works
Dosage & preparation
Preparation
Comparisons
Other
Highlighted claims
- The LDR brachytherapy prescription dose target is 145 Gy. — The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1–3 prostate cancer
- LDR brachytherapy is a day-case interventional radiotherapy procedure involving permanent implantation of radioactive iodine-125 seeds into the prostate. — The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1–3 prostate cancer
- Iodine-125 in LDR brachytherapy has a 60-day half-life, so radiation dose accumulates gradually over months. — The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1–3 prostate cancer
- LDR implantation is performed under general or spinal anesthesia, followed by postimplant CT within 24 hours for dosimetric quality assurance. — The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1–3 prostate cancer
- LDR brachytherapy delivers continuous local radiation from a single implant, unlike high-dose-rate brachytherapy delivered through temporary catheters. — The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1–3 prostate cancer
- For the LDR arm, preoperative TRUS measurements are used by a web-based nomogram to calculate seed requirements. — The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1–3 prostate cancer